Authors’ Response

Abstract

Get full access to this article

View all access options for this article.

References

Schiele

van Ryn

Canada

. A specific antidote for dabigatran: functional and structural characterization. Blood. 2013;121(18):3554–3562.

Grottke

Van Ryn

Rossaint

In a trauma experimental pig model prothrombin complex concentrates and a specific antidote (idarucizumab) are effective to reverse the anticoagulant effects of dabigatran. Critical Care. 2014;18(suppl 1):P118.

Glund

Stangier

Schmohl

. A specific antidote for dabigatran: immediate, complete, and sustained reversal of dabigatran-induced anticoagulation in healthy male volunteers. Circulation 2013;128(22 suppl): Abstr 17765. Presented at the 86th Scientific Sessions of the American Heart Association; November 18, 2013; Dallas, TX.

Kumar

Smith

Henry

. A review and recommendations for the management of patients with life-threatening dabigatran associated hemorrhage: a single-center university hospital experience [published online March 25, 2014]. J Int Care Med. 2014.

Singh

Maw

Henry

. Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience. Clin J Am Soc Nephrol. 2013;8(9):1533–1539.